Compare REYN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REYN | STVN |
|---|---|---|
| Founded | 1947 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2019 | 2021 |
| Metric | REYN | STVN |
|---|---|---|
| Price | $25.79 | $17.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $24.83 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 996.5K | 344.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.47% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $3,756,000,000.00 | N/A |
| Revenue This Year | $1.91 | $9.67 |
| Revenue Next Year | $1.82 | $9.99 |
| P/E Ratio | $87.46 | ★ $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.44 | $12.89 |
| 52 Week High | $26.25 | $28.00 |
| Indicator | REYN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 81.28 | 46.00 |
| Support Level | $23.21 | $16.27 |
| Resistance Level | $26.25 | $17.19 |
| Average True Range (ATR) | 0.60 | 0.90 |
| MACD | 0.23 | -0.14 |
| Stochastic Oscillator | 97.85 | 24.00 |
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.